Hong Kong Stock Market Movement | GIANT BIOGENE (02367) Drops Over 3%, Hitting Yearly Low—Stock Price Halved from May Peak as RejuvaBio's Double 11 Ranking Declines

Stock News11-20

GIANT BIOGENE (02367) fell more than 3%, touching a yearly low of HK$35.54. Since late May, the stock has plummeted amid controversy over collagen ingredients, with its current price now halved from the May peak. At the time of writing, it was down 3.46% to HK$35.68, with a turnover of HK$199 million.

Market sources indicate that according to industry data, domestic brands secured five spots in the top 10 of this year's Double 11 Douyin beauty rankings. However, RejuvaBio, a brand under GIANT BIOGENE, dropped out of the top 10. On Tmall's beauty ranking, RejuvaBio ranked 18th, down five spots from last year. Additionally, reports note that RejuvaBio, which previously held a strong position on Douyin's beauty charts, has consistently fallen out of the top 20 since June.

Jianghai Securities suggests that competition in the recombinant collagen sector is intensifying, advising investors to monitor GIANT BIOGENE's future marketing strategies and sales performance for this product.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1114836375?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-20 14:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1114836375","market":"hk","top_or_hot":-1,"title":"Hong Kong Stock Market Movement | GIANT BIOGENE (02367) Drops Over 3%, Hitting Yearly Low—Stock Price Halved from May Peak as RejuvaBio's Double 11 Ranking Declines","media":"Stock News","content":"<p>GIANT BIOGENE (02367) fell more than 3%, touching a yearly low of HK$35.54. Since late May, the stock has plummeted amid controversy over collagen ingredients, with its current price now halved from the May peak. At the time of writing, it was down 3.46% to HK$35.68, with a turnover of HK$199 million.</p>\n<p>Market sources indicate that according to industry data, domestic brands secured five spots in the top 10 of this year's Double 11 Douyin beauty rankings. However, RejuvaBio, a brand under GIANT BIOGENE, dropped out of the top 10. On Tmall's beauty ranking, RejuvaBio ranked 18th, down five spots from last year. Additionally, reports note that RejuvaBio, which previously held a strong position on Douyin's beauty charts, has consistently fallen out of the top 20 since June.</p>\n<p>Jianghai Securities suggests that competition in the recombinant collagen sector is intensifying, advising investors to monitor GIANT BIOGENE's future marketing strategies and sales performance for this product.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stock Market Movement | GIANT BIOGENE (02367) Drops Over 3%, Hitting Yearly Low—Stock Price Halved from May Peak as RejuvaBio's Double 11 Ranking Declines</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stock Market Movement | GIANT BIOGENE (02367) Drops Over 3%, Hitting Yearly Low—Stock Price Halved from May Peak as RejuvaBio's Double 11 Ranking Declines\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-20 14:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>GIANT BIOGENE (02367) fell more than 3%, touching a yearly low of HK$35.54. Since late May, the stock has plummeted amid controversy over collagen ingredients, with its current price now halved from the May peak. At the time of writing, it was down 3.46% to HK$35.68, with a turnover of HK$199 million.</p>\n<p>Market sources indicate that according to industry data, domestic brands secured five spots in the top 10 of this year's Double 11 Douyin beauty rankings. However, RejuvaBio, a brand under GIANT BIOGENE, dropped out of the top 10. On Tmall's beauty ranking, RejuvaBio ranked 18th, down five spots from last year. Additionally, reports note that RejuvaBio, which previously held a strong position on Douyin's beauty charts, has consistently fallen out of the top 20 since June.</p>\n<p>Jianghai Securities suggests that competition in the recombinant collagen sector is intensifying, advising investors to monitor GIANT BIOGENE's future marketing strategies and sales performance for this product.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02367","symbol_name":"巨子生物","start_time":0,"source_url":"","article_id":"1114836375","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1114836375","pubTimestamp":1763621545,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"GIANT BIOGENE (02367) fell more than 3%, touching a yearly low of HK$35.54. Since late May, the stock has plummeted amid controversy over collagen ingredients, with its current price now halved from...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02367":"巨子生物","SG9999004311.SGD":"Nikko AM Shenton Emerging Enterprise Discovery Fund SGD","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","BK1207":"个人用品"},"translate_title":"港股动向|巨人生物(02367)跌超3%创年内新低-股价较5月高峰腰斩因RejuvaBio双11排名下滑","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02367":1},"content_text":"GIANT BIOGENE (02367) fell more than 3%, touching a yearly low of HK$35.54. Since late May, the stock has plummeted amid controversy over collagen ingredients, with its current price now halved from the May peak. At the time of writing, it was down 3.46% to HK$35.68, with a turnover of HK$199 million.\nMarket sources indicate that according to industry data, domestic brands secured five spots in the top 10 of this year's Double 11 Douyin beauty rankings. However, RejuvaBio, a brand under GIANT BIOGENE, dropped out of the top 10. On Tmall's beauty ranking, RejuvaBio ranked 18th, down five spots from last year. Additionally, reports note that RejuvaBio, which previously held a strong position on Douyin's beauty charts, has consistently fallen out of the top 20 since June.\nJianghai Securities suggests that competition in the recombinant collagen sector is intensifying, advising investors to monitor GIANT BIOGENE's future marketing strategies and sales performance for this product.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1114836375","isCrawlerRequest":true}